European Healthtech startup funding raised during Q2 2016.
In Q2 2016, 94 European Healthtech companies raised a combined €652M across 98 funding rounds, up 152.7% versus Q2 2015. Israel led by capital raised, and Bayern Kapital was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| F2G | Growth/Late | May 2016 | €55M |
| Brillen.de | Growth/Late | Jun 2016 | €45M |
| AC Immune | Series D+ | Apr 2016 | €40M |
| CRISPR Therapeutics | Series B | May 2016 |
9 exits · €619M disclosed.
| EngMab | Acquisition | Apr 2016 | €545M |
| Creo Medical | IPO | Jun 2016 | €74M |
| €35M |
| Impulse Dynamics | Growth/Late | Apr 2016 | €30M |
| EarlySense | Series D+ | May 2016 | €23M |
| Allecra Therapeutics | Series B | May 2016 | €22M |
| apotea.se | Growth/Late | Apr 2016 | €22M |
| Cambridge Medical Robotics | Series A | Jun 2016 | €18M |
| Aspect Imaging | Growth/Late | Jun 2016 | €18M |
| Simplee | Series C | Apr 2016 | €18M |
| docplanner | Series C | May 2016 | €18M |
| Nyxoah | Series B | Jun 2016 | €18M |
| Medical Imaging Partnership | Growth/Late | Apr 2016 | €17M |
| Aleva Neurotherapeutics | Series C | Apr 2016 | €16M |
